News &amp; Updates

A recent study has found that laughing can be as effective as artificial tears (ie, 0.1% sodium hyaluronic acid eye drop) in relieving ocular surface discomfort in patients with dry eye disease (DED) with limited corneal staining.

Laughter is ‘best’ medicine for dry eye disease

24 Sep 2024

$5-fraction preoperative RT exhibits top-notch local control for soft tissue sarcoma$

5-fraction preoperative RT exhibits top-notch local control for soft tissue sarcoma

Patients with soft tissue sarcoma (STS) who underwent preoperative 5-fraction radiation therapy (RT) exhibit excellent 2-year local control with major wound complications (MWC) and experience toxicity akin to standard fractionation preoperative RT, a study has shown.

5-fraction preoperative RT exhibits top-notch local control for soft tissue sarcoma

Women with asthma more likely to need fertility treatment

Women with asthma have a higher likelihood of necessitating fertility treatment, according to a Danish nationwide historical cohort study presented at ERS 2024.

Women with asthma more likely to need fertility treatment

24 Sep 2024

Maternity leave extension in HK lowers postnatal depression rate by 22 percent

Paid maternity leave extension to 14 weeks in Hong Kong led to a 22 percent reduction in the rate of probable postnatal depression, researchers from the University of Hong Kong (HKU) and the National University of Singapore (NUS) have reported.

Maternity leave extension in HK lowers postnatal depression rate by 22 percent

24 Sep 2024

Brief inpatient CBT promising for suicide prevention

Brief cognitive behavioural therapy (CBT) delivered in inpatient settings appears to lower the rate of repeat suicide attempts and readmissions among individuals admitted to psychiatric hospitals, according to a study.

Brief inpatient CBT promising for suicide prevention

Liraglutide induces weight loss in kids with obesity

Adding once-daily subcutaneous liraglutide to lifestyle interventions reduces BMI in children aged 6 to <12 years with obesity, according to the SCALE Kids trial presented at EASD 2024.

Liraglutide induces weight loss in kids with obesity

Rimegepant for long-term acute Tx of migraine cuts monthly attack days, shows no MOH signal

In patients with ≥1 year’s history of migraine and ≥6 monthly migraine days (MMDs), acute treatment of migraine with rimegepant 75 mg up to once daily as needed for up to 52 weeks is associated with reduced MMDs, with no increase in monthly tablet utilization and no evidence of medication overuse headache (MOH), a post hoc analysis of an open-label safety study has shown.

Rimegepant for long-term acute Tx of migraine cuts monthly attack days, shows no MOH signal

Poststroke seizures, epilepsy tied to increased dementia risk

Stroke survivors with seizures or epilepsy are at greater risk of dementia, according to a retrospective study.

Poststroke seizures, epilepsy tied to increased dementia risk

Long-term freedom from insulin may be achieved with duodenal electroporation plus semaglutide

23 Sep 2024 by

The combination of re-cellularization via electroporation therapy (ReCET) plus semaglutide appears to improve glucose control and metabolic health and eliminate the need for insulin therapy in most patients with type 2 diabetes (T2D), with the effects maintained up to 2 years, according to the follow-up data from the single-arm, dose-finding, first-in-human EMINENT trial.

Long-term freedom from insulin may be achieved with duodenal electroporation plus semaglutide

23 Sep 2024

Late recovery of LV function tied to poor survival in patients with Takotsubo syndrome

In patients with Takotsubo syndrome (TTS), late recovery of left ventricular (LV) function appears to contribute to reduced short- and long-term survival, suggests a study.

Late recovery of LV function tied to poor survival in patients with Takotsubo syndrome